The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Shrimps Disease Diagnostic Market Research Report 2025
Synopsis
Shrimps Production are increasing on the global level especially in Asia Pacific countries such as India and China. Shrimp farming is gaining popularity for production of shrimp for human consumption. Bacterial and viral infections are a major threat to the shrimp production industry in various countries. Shrimp production in many countries continues to face economic losses due to different diseases.
The global Shrimps Disease Diagnostic market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Shrimps Disease Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Shrimps Disease Diagnostic.
Report Scope
The Shrimps Disease Diagnostic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Shrimps Disease Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Shrimps Disease Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
HiMedia Laboratories
Speedy Assay Sdn Bhd
REAGEN LLC
FUJIKURA KASEI CO., LTD
GeneReach Biotechnology Corp
Thermo Fisher Scientific
Lab - Ind Resource Sdn Bhd
AquaBounty Technologies, Inc
pop bio
SUREBIO
Auro Biotechnologies
Segment by Type
WSSV (White Spot Syndrome Virus)
TSV (Taura Syndrome Virus)
YHV/GAV (Yellow Head/Gill Associated Virus)
IHHNV (Infectious Hypodermal and Hematopoietic Virus)
HPV (Hepatopancreatic Parvovirus)
MBV (Monodon Baculovirus)
IMNV (Infectious Myonecrosis Virus)
NHP-B (Necrotising Hepatopancreatitis Bacteria)
MoV (Mourilyan Virus)
Early Mortality Syndrome (EMS)
Segment by Application
Fisheries
Aquaculture Laboratories
Marine Laboratories
Education and Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Shrimps Disease Diagnostic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Shrimps Production are increasing on the global level especially in Asia Pacific countries such as India and China. Shrimp farming is gaining popularity for production of shrimp for human consumption. Bacterial and viral infections are a major threat to the shrimp production industry in various countries. Shrimp production in many countries continues to face economic losses due to different diseases.
The global Shrimps Disease Diagnostic market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Shrimps Disease Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Shrimps Disease Diagnostic.
Report Scope
The Shrimps Disease Diagnostic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Shrimps Disease Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Shrimps Disease Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
HiMedia Laboratories
Speedy Assay Sdn Bhd
REAGEN LLC
FUJIKURA KASEI CO., LTD
GeneReach Biotechnology Corp
Thermo Fisher Scientific
Lab - Ind Resource Sdn Bhd
AquaBounty Technologies, Inc
pop bio
SUREBIO
Auro Biotechnologies
Segment by Type
WSSV (White Spot Syndrome Virus)
TSV (Taura Syndrome Virus)
YHV/GAV (Yellow Head/Gill Associated Virus)
IHHNV (Infectious Hypodermal and Hematopoietic Virus)
HPV (Hepatopancreatic Parvovirus)
MBV (Monodon Baculovirus)
IMNV (Infectious Myonecrosis Virus)
NHP-B (Necrotising Hepatopancreatitis Bacteria)
MoV (Mourilyan Virus)
Early Mortality Syndrome (EMS)
Segment by Application
Fisheries
Aquaculture Laboratories
Marine Laboratories
Education and Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Shrimps Disease Diagnostic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Shrimps Disease Diagnostic Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 WSSV (White Spot Syndrome Virus)
1.2.3 TSV (Taura Syndrome Virus)
1.2.4 YHV/GAV (Yellow Head/Gill Associated Virus)
1.2.5 IHHNV (Infectious Hypodermal and Hematopoietic Virus)
1.2.6 HPV (Hepatopancreatic Parvovirus)
1.2.7 MBV (Monodon Baculovirus)
1.2.8 IMNV (Infectious Myonecrosis Virus)
1.2.9 NHP-B (Necrotising Hepatopancreatitis Bacteria)
1.2.10 MoV (Mourilyan Virus)
1.2.11 Early Mortality Syndrome (EMS)
1.3 Market by Application
1.3.1 Global Shrimps Disease Diagnostic Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Fisheries
1.3.3 Aquaculture Laboratories
1.3.4 Marine Laboratories
1.3.5 Education and Research Institutes
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Shrimps Disease Diagnostic Market Perspective (2019-2030)
2.2 Shrimps Disease Diagnostic Growth Trends by Region
2.2.1 Global Shrimps Disease Diagnostic Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Shrimps Disease Diagnostic Historic Market Size by Region (2019-2024)
2.2.3 Shrimps Disease Diagnostic Forecasted Market Size by Region (2025-2030)
2.3 Shrimps Disease Diagnostic Market Dynamics
2.3.1 Shrimps Disease Diagnostic Industry Trends
2.3.2 Shrimps Disease Diagnostic Market Drivers
2.3.3 Shrimps Disease Diagnostic Market Challenges
2.3.4 Shrimps Disease Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Shrimps Disease Diagnostic Players by Revenue
3.1.1 Global Top Shrimps Disease Diagnostic Players by Revenue (2019-2024)
3.1.2 Global Shrimps Disease Diagnostic Revenue Market Share by Players (2019-2024)
3.2 Global Shrimps Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Shrimps Disease Diagnostic Revenue
3.4 Global Shrimps Disease Diagnostic Market Concentration Ratio
3.4.1 Global Shrimps Disease Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Shrimps Disease Diagnostic Revenue in 2023
3.5 Shrimps Disease Diagnostic Key Players Head office and Area Served
3.6 Key Players Shrimps Disease Diagnostic Product Solution and Service
3.7 Date of Enter into Shrimps Disease Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Shrimps Disease Diagnostic Breakdown Data by Type
4.1 Global Shrimps Disease Diagnostic Historic Market Size by Type (2019-2024)
4.2 Global Shrimps Disease Diagnostic Forecasted Market Size by Type (2025-2030)
5 Shrimps Disease Diagnostic Breakdown Data by Application
5.1 Global Shrimps Disease Diagnostic Historic Market Size by Application (2019-2024)
5.2 Global Shrimps Disease Diagnostic Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Shrimps Disease Diagnostic Market Size (2019-2030)
6.2 North America Shrimps Disease Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Shrimps Disease Diagnostic Market Size by Country (2019-2024)
6.4 North America Shrimps Disease Diagnostic Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Shrimps Disease Diagnostic Market Size (2019-2030)
7.2 Europe Shrimps Disease Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Shrimps Disease Diagnostic Market Size by Country (2019-2024)
7.4 Europe Shrimps Disease Diagnostic Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Shrimps Disease Diagnostic Market Size (2019-2030)
8.2 Asia-Pacific Shrimps Disease Diagnostic Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Shrimps Disease Diagnostic Market Size by Region (2019-2024)
8.4 Asia-Pacific Shrimps Disease Diagnostic Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Shrimps Disease Diagnostic Market Size (2019-2030)
9.2 Latin America Shrimps Disease Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Shrimps Disease Diagnostic Market Size by Country (2019-2024)
9.4 Latin America Shrimps Disease Diagnostic Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Shrimps Disease Diagnostic Market Size (2019-2030)
10.2 Middle East & Africa Shrimps Disease Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Shrimps Disease Diagnostic Market Size by Country (2019-2024)
10.4 Middle East & Africa Shrimps Disease Diagnostic Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 HiMedia Laboratories
11.1.1 HiMedia Laboratories Company Detail
11.1.2 HiMedia Laboratories Business Overview
11.1.3 HiMedia Laboratories Shrimps Disease Diagnostic Introduction
11.1.4 HiMedia Laboratories Revenue in Shrimps Disease Diagnostic Business (2019-2024)
11.1.5 HiMedia Laboratories Recent Development
11.2 Speedy Assay Sdn Bhd
11.2.1 Speedy Assay Sdn Bhd Company Detail
11.2.2 Speedy Assay Sdn Bhd Business Overview
11.2.3 Speedy Assay Sdn Bhd Shrimps Disease Diagnostic Introduction
11.2.4 Speedy Assay Sdn Bhd Revenue in Shrimps Disease Diagnostic Business (2019-2024)
11.2.5 Speedy Assay Sdn Bhd Recent Development
11.3 REAGEN LLC
11.3.1 REAGEN LLC Company Detail
11.3.2 REAGEN LLC Business Overview
11.3.3 REAGEN LLC Shrimps Disease Diagnostic Introduction
11.3.4 REAGEN LLC Revenue in Shrimps Disease Diagnostic Business (2019-2024)
11.3.5 REAGEN LLC Recent Development
11.4 FUJIKURA KASEI CO., LTD
11.4.1 FUJIKURA KASEI CO., LTD Company Detail
11.4.2 FUJIKURA KASEI CO., LTD Business Overview
11.4.3 FUJIKURA KASEI CO., LTD Shrimps Disease Diagnostic Introduction
11.4.4 FUJIKURA KASEI CO., LTD Revenue in Shrimps Disease Diagnostic Business (2019-2024)
11.4.5 FUJIKURA KASEI CO., LTD Recent Development
11.5 GeneReach Biotechnology Corp
11.5.1 GeneReach Biotechnology Corp Company Detail
11.5.2 GeneReach Biotechnology Corp Business Overview
11.5.3 GeneReach Biotechnology Corp Shrimps Disease Diagnostic Introduction
11.5.4 GeneReach Biotechnology Corp Revenue in Shrimps Disease Diagnostic Business (2019-2024)
11.5.5 GeneReach Biotechnology Corp Recent Development
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Detail
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific Shrimps Disease Diagnostic Introduction
11.6.4 Thermo Fisher Scientific Revenue in Shrimps Disease Diagnostic Business (2019-2024)
11.6.5 Thermo Fisher Scientific Recent Development
11.7 Lab - Ind Resource Sdn Bhd
11.7.1 Lab - Ind Resource Sdn Bhd Company Detail
11.7.2 Lab - Ind Resource Sdn Bhd Business Overview
11.7.3 Lab - Ind Resource Sdn Bhd Shrimps Disease Diagnostic Introduction
11.7.4 Lab - Ind Resource Sdn Bhd Revenue in Shrimps Disease Diagnostic Business (2019-2024)
11.7.5 Lab - Ind Resource Sdn Bhd Recent Development
11.8 AquaBounty Technologies, Inc
11.8.1 AquaBounty Technologies, Inc Company Detail
11.8.2 AquaBounty Technologies, Inc Business Overview
11.8.3 AquaBounty Technologies, Inc Shrimps Disease Diagnostic Introduction
11.8.4 AquaBounty Technologies, Inc Revenue in Shrimps Disease Diagnostic Business (2019-2024)
11.8.5 AquaBounty Technologies, Inc Recent Development
11.9 pop bio
11.9.1 pop bio Company Detail
11.9.2 pop bio Business Overview
11.9.3 pop bio Shrimps Disease Diagnostic Introduction
11.9.4 pop bio Revenue in Shrimps Disease Diagnostic Business (2019-2024)
11.9.5 pop bio Recent Development
11.10 SUREBIO
11.10.1 SUREBIO Company Detail
11.10.2 SUREBIO Business Overview
11.10.3 SUREBIO Shrimps Disease Diagnostic Introduction
11.10.4 SUREBIO Revenue in Shrimps Disease Diagnostic Business (2019-2024)
11.10.5 SUREBIO Recent Development
11.11 Auro Biotechnologies
11.11.1 Auro Biotechnologies Company Detail
11.11.2 Auro Biotechnologies Business Overview
11.11.3 Auro Biotechnologies Shrimps Disease Diagnostic Introduction
11.11.4 Auro Biotechnologies Revenue in Shrimps Disease Diagnostic Business (2019-2024)
11.11.5 Auro Biotechnologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
